$DOC News

Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $20

Scotiabank Maintains Sector Perform on Healthpeak Properties, Raises Price Target to $21

Morgan Stanley Maintains Overweight on Healthpeak Properties, Raises Price Target to $20

A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum

Baird Raises its Price Target on Healthpeak Properties (DOC)

RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $21

This Healthcare REIT Stands Out With 6.3% Yield

Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns

UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $19

Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $21

Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $20

Healthpeak Properties Q1 Earnings Call Highlights

Is It Too Late To Reassess Healthpeak Properties (DOC) After Its Recent 21% Share Price Jump?

Healthpeak Properties, Inc. (DOC) Q1 2026 Earnings Call Transcript

Healthpeak Properties Q1 FFOA Tops Estimates on Steady Leasing Momentum

Healthpeak Properties, Inc. Q1 2026 Earnings Call Summary

Healthpeak (DOC) Q1 FFO and Revenues Surpass Estimates

Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results

Healthpeak Properties Raises FY2026 FFO Guidance from $1.70-$1.74 to $1.71-$1.75 vs $1.75 Est

Healthpeak Properties Q1 FFO $0.45 Beats $0.43 Estimate, Sales $752.952M Beat $694.560M Estimate